Phillip Gross is 10% at AMAG PHARMACEUTICALS INC. (AMAG). They have made 14 open-market trades across 8 companies since 2009, most recently 2025-10-16.
CIK 0001403413
11 open-market purchases totalling $55.9M since 2009, against 3 sales. Across 11 scored buys the stock is down 1.7% at ninety days, and 1.9 points behind the S&P over the same stretch.
11 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 45% | 45% |
| Avg Move | -25.9% | -1.7% | -1.7% |
| Alpha | -20.1% | -1.9% | -1.9% |
| Scored | 11 | 11 | 11 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PRAX | SELL · Routine | 2025-10-16 | 2025-10-17 | $105.76 | $33.2M | +3.0% | +4.0% | +56.7% |
| MULE | SELL | 2017-03-17 | 2017-03-21 | $25.06 | $627K | +2.2% | -6.3% | +5.9% |
| CALA | BUY | 2015-09-22 | 2015-09-24 | $6.03 | $645K | -32.6% | +0.3% | +0.3% |
| CALA | BUY | 2015-08-26 | 2015-08-28 | $5.27 | $908K | -32.6% | +0.3% | +0.3% |
| ADXS | BUY | 2015-08-20 | 2015-08-24 | $14.15 | $4.2M | -17.7% | +0.5% | +0.5% |
| ADXS | BUY | 2015-04-30 | 2015-05-04 | $19.00 | $9.5M | -17.7% | +0.5% | +0.5% |
| ADXS | BUY | 2015-02-18 | 2015-02-20 | $7.50 | $5.1M | -17.7% | +0.5% | +0.5% |
| BDBD | SELL | 2012-12-28 | 2013-01-02 | $12.88 | $2.8M | N/A | N/A | N/A |
| SMBL | SELL | 2012-12-20 | 2012-12-21 | $13.52 | $3.5M | N/A | N/A | N/A |
| PBYI | BUY | 2012-10-18 | 2012-10-22 | $16.00 | $9.8M | -37.6% | -4.0% | -4.0% |
| PBYI | BUY | 2012-07-25 | 2012-07-27 | $12.48 | $5.8M | -37.6% | -4.0% | -4.0% |
| PBYI | BUY | 2012-04-24 | 2012-04-26 | $14.00 | $1.4M | -37.6% | -4.0% | -4.0% |
| AMAG | BUY | 2010-10-29 | 2010-11-02 | $15.87 | $15.9M | -23.6% | -3.6% | -3.6% |
| SCSS | BUY | 2009-12-08 | 2009-12-10 | $4.75 | $475K | -6.6% | -1.0% | -1.0% |
| AMAG | BUY | 2009-03-09 | 2009-03-11 | $25.41 | $2.1M | -23.6% | -3.6% | -3.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| ADXS | 5,939,366 | $1.4M |
| BDBD | 6,619,918 | — |
| SMBL | 6,850,422 | — |
| Total | $975.1M |
Shares reported on the most recent Form 4, priced at the 2025-10-17 close. 2 holdings could not be priced and are excluded from the total.